[Predictive validity of Clinical Risk Groups in chronic patients in primary healthcare]. / Validez predictiva del Clinical Risk Groups en pacientes crónicos en el ambito de la atencion primaria.

OBJECTIVE: To analyse a prediction model for admissions and hospital emergencies based on Clinical Risk Groups, in a population of complex chronic patients demanding primary care. DESIGN: A multicentric retrospective observational study, of a cohort of chronic patients with comorbidity, from January until December 2013. PLACE: The study population was assigned to the Santa Pola and Raval health centres from the Health Department of Elche. PARTICIPANTS: Cohort of chronic patients with comorbidity, from January to December 2013. INTERVENTIONS: Data about the number of admissions, reasons and complexity level associated with the admission were collected by the review of medical records. MAIN MEASURES: To determine the level of complexity, the classification included in the chronicity strategy of the Valencian Community based on Clinical Risk Groups was used. RESULTS: Five hundred and four patients were recruited with a high complexity degree (N3) and 272 with moderate/low complexity (N1-N2). A higher comorbidity was observed in N3 patients with high complexity [Charlson 2.9 (DE 1.8) vs. 1.9 (DE 1.3); P<.001], and higher dependence degree for basic diary activities [Barthel 16.1 (n=81) vs. 7.3 (n=20); P<.001]. Association between the number of admissions [0.4 (DE 0.8) vs. 0.1 (DE 0.5); P<.001] and emergency visits [0.8 (DE 1.5) vs. 0.3 (DE 0.8), P<.001] was significatively higher in patients from N3 group than N1-N2 groups. CONCLUSIONS: The predictive capacity of CRG grouper showed high sensibility for the patient classification with a high degree of complexity. Its specificity and positive predictive value were lower for the association of the N3 complexity stratum.

Diabetes Does Not Increase the Risk of Hospitalization Due to COVID-19 in Patients Aged 50 Years or Older in Primary Care-APHOSDIAB-COVID-19 Multicenter Study.

The purpose of this study was to identify clinical, analytical, and sociodemographic variables associated with the need for hospital admission in people over 50 years infected with SARS-CoV-2 and to assess whether diabetes mellitus conditions the risk of hospitalization. A multicenter case-control study analyzing electronic medical records in patients with COVID-19 from 1 March 2020 to 30 April 2021 was conducted. We included 790 patients: 295 cases admitted to the hospital and 495 controls. Under half (n = 386, 48.8%) were women, and 8.5% were active smokers. The main comorbidities were hypertension (50.5%), dyslipidemia, obesity, and diabetes (37.5%). Multivariable logistic regression showed that hospital admission was associated with age above 65 years (OR from 2.45 to 3.89, ascending with age group); male sex (OR 2.15, 95% CI 1.47-3.15), fever (OR 4.31, 95% CI 2.87-6.47), cough (OR 1.89, 95% CI 1.28-2.80), asthenia/malaise (OR 2.04, 95% CI 1.38-3.03), dyspnea (4.69, 95% CI 3.00-7.33), confusion (OR 8.87, 95% CI 1.68-46.78), and a history of hypertension (OR 1.61, 95% CI 1.08-2.41) or immunosuppression (OR 4.97, 95% CI 1.45-17.09). Diabetes was not associated with increased risk of hospital admission (OR 1.18, 95% CI 0.80-1.72; p = 0.38). Diabetes did not increase the risk of hospital admission in people over 50 years old, but advanced age, male sex, fever, cough, asthenia, dyspnea/confusion, and hypertension or immunosuppression did.

A scoring system to detect fixed airflow limitation in smokers from simple easy-to-use parameters.

No validated screening method currently exists for Chronic Obstructive Pulmonary Disease (COPD) in smokers. Therefore, we constructed a predictive model with simple parameters that can be applied for COPD screening to detect fixed airflow limitation. This observational cross-sectional study included a random sample of 222 smokers with no previous diagnosis of COPD undertaken in a Spanish region in 2014-2016. The main variable was fixed airflow limitation by spirometry. The secondary variables (COPD factors) were: age, gender, smoking (pack-years and Fagerström test), body mass index, educational level, respiratory symptoms and exacerbations. A points system was developed to predict fixed airflow limitation based on secondary variables. The model was validated internally through bootstrapping, determining discrimination and calibration. The system was then integrated into a mobile application for Android. Fifty-seven patients (25.7%) presented fixed airflow limitation. The points system included as predictors: age, pack-years, Fagerström test and presence of respiratory symptoms. Internal validation of the system was very satisfactory, both in discrimination and calibration. In conclusion, a points system has been constructed to predict fixed airflow limitation in smokers with no previous COPD. This system can be integrated as a screening tool, though it should be externally validated in other geographical regions.

Telemedicine in Primary Care for Patients With Chronic Conditions: The ValCrònic Quasi-Experimental Study.

BACKGROUND: The increase of chronic diseases prevalence has created the need to adapt care models and to provide greater home supervision. OBJECTIVE: The objective of our study was to evaluate the impact of telemonitoring on patients with long-term conditions at high risk for rehospitalization or an emergency department visit, in terms of target disease control (diabetes, hypertension, heart failure, and chronic obstructive pulmonary disease). METHODS: We conducted a quasi-experimental study with a before-and-after analysis to assess the effectiveness of the ValCrònic program after 1 year of primary care monitoring. The study included high-risk patients with 1 or more of the following conditions: diabetes, high blood pressure, heart failure, and chronic obstructive pulmonary disease. We assessed risk according to the Community Assessment Risk Screen. Participants used an electronic device (tablet) to self-report relevant health information, which was then automatically entered into their eHealth record for consultation. RESULTS: The total sample size was 521 patients. Compared with the preintervention year, there were significant reductions in weight (82.3 kg before vs 80.1 kg after; P=.001) and in the proportion of people with high systolic (≥140 mmHg; 190, 36.5% vs 170, 32.6%; P=.001) and diastolic (≥90 mmHg; 72, 13.8% vs 40, 7.7%; P=.01) blood pressures, and hemoglobin A1c ≥8% (186, 35.7% vs 104, 20.0%; P=.001). There was also a decrease in the proportion of participants who used emergency services in primary care (68, 13.1% vs 33, 6.3%; P<.001) and in hospital (98, 18.8% vs 67, 12.8%; P<.001). Likewise, fewer participants required hospital admission due to an emergency (105, 20.2% vs 71, 13.6%; P<.001) or disease exacerbation (55, 10.5% vs 42, 8.1%; P<.001). CONCLUSIONS: The ValCrònic telemonitoring program in patients at high risk for rehospitalization or an emergency department visit appears to be useful to improve target disease control and to reduce the use of resources.

[Evaluation of satisfaction with telemedicine devices and with the results of the care received among chronic patients. The ValCrònic program]. / Evaluación de la satisfacción de los pacientes crónicos con los dispositivos de telemedicina y con el resultado de la atención recibida. Programa ValCrònic.

OBJECTIVE: To evaluate patient satisfaction with the ValCrònic program, telemedicine devices, and the results of the care received after a 2-year follow-up. DESIGN: Observational, descriptive study based on telephone surveys. SETTING: The autonomous community of Valencia (Spain). PARTICIPANTS: Participants consisted of 410 patients with one or more of the following diseases: hypertension, heart failure, diabetes, or chronic obstructive pulmonary disease. A total of 585 patients were included, of whom 104 left the program (18 due to death) and 71 refused to participate. METHODS: We designed and validated a specific scale. Floor and ceiling effects were considered. Internal consistency was analyzed using Cronbach's alpha. RESULTS: Responses were obtained from 322 patients (response rate, 78.5%). Of these, 118 (36.6%) were women. In 48 patients (14.9%), the person responding was a caregiver. Cronbach's alpha was 0.7. For 278 patients (86.3%), the ValCrònic program helped them to understand their disease better, 270 (83.9%) reported that it helped them use their medication more safely, and 283 (87.9%) reported they had better knowledge of their disease. For 288 (89.4%), the devices were easy to manage at home. Only 12 patients (3.7%) found that the devices involved a heavy workload that was difficult to incorporate into their daily lives. CONCLUSIONS: The ValCrònic program promotes self-care among patients.

Evaluación de la satisfacción de los pacientes crónicos con los dispositivos de telemedicina y con el resultado de la atención recibida. Programa ValCrònic / Evaluation of satisfaction with telemedicine devices and with the results of the care received among chronic patients. The ValCrònic program

OBJETIVO: Evaluar la satisfacción de los pacientes con el programa ValCrònic, los dispositivos de telemedicina y con el resultado de la atención recibida tras 2 años de seguimiento. DISEÑO: Estudio observacional descriptivo basado en encuestas telefónicas. Emplazamiento: Comunidad Valenciana. Participantes: En total participaron 410 pacientes que presentaban una o varias de las siguientes patologías: hipertensión, insuficiencia cardíaca, diabetes o enfermedad pulmonar obstructiva crónica. Se incluyó a 585 pacientes, de los cuales 104 abandonaron el programa (18 por fallecimiento) y 71 rehusaron participar. MÉTODOS: Se diseñó y validó una escala específica. Se consideraron los efectos techo y suelo. Se analizó la consistencia interna mediante alfa de Cronbach. Para comprobar la validez de constructo se empleó un análisis exploratorio de componentes principales con criterio de autovaloración igual a 1. Se aplicó el procedimiento de rotación Varimax. Se consideraron como pérdidas aceptables de información cargas factoriales ≥ 0,55. La escala se conformó con 7 preguntas cerradas y 1 abierta. RESULTADOS: Respondieron un total de 322 pacientes (tasa de respuesta del 78,5%). 118 (36.6%) fueron mujeres. En 48 (14,9%) casos respondió un cuidador. El valor del alfa de Cronbach fue de 0,7. ValCrònic supuso para 278 (86,3%) pacientes una ayuda para conocer mejor su enfermedad, 270 (83,9%) afirmaron hacer un uso más seguro de la medicación gracias a ValCrònic y 283 (87,9%) dijeron conocer ahora mejor su enfermedad. Para 288 (89,4%) los dispositivos fueron fáciles de manejar en casa. Solo en 12 (3,7%) casos el paciente consideró que los dispositivos de telemedicina suponían una carga de trabajo difícil de conciliar en su día a día. CONCLUSIONES: ValCrònic ha contribuido a la activación de los pacientes para autocuidado

OBJECTIVE: To evaluate patient satisfaction with the ValCrònic program, telemedicine devices, and the results of the care received after a 2-year follow-up. DESIGN: Observational, descriptive study based on telephone surveys. Setting: The autonomous community of Valencia (Spain). Participants: Participants consisted of 410 patients with one or more of the following diseases: hypertension, heart failure, diabetes, or chronic obstructive pulmonary disease. A total of 585 patients were included, of whom 104 left the program (18 due to death) and 71 refused to participate. METHODS: We designed and validated a specfic scale. Floor and ceiling effects were considered. Internal consistency was analyzed using Cronbach's alpha. RESULTS: Responses were obtained from 322 patients (response rate, 78.5%). Of these, 118 (36.6%) were women. In 48 patients (14.9%), the person responding was a caregiver. Cronbach's alpha was 0.7. For 278 patients (86.3%), the ValCrònic program helped them to understand their disease better, 270 (83.9%) reported that it helped them use their medication more safely, and283 (87.9%) reported they had better knowledge of their disease. For 288 (89.4%), the devices were easy to manage at home. Only 12 patients (3.7%) found that the devices involved a heavy workload that was difficult to incorporate into their daily lives. CONCLUSIONS: The ValCrònic program promotes self-care among patients

Physician patient communication failure facilitates medication errors in older polymedicated patients with multiple comorbidities.

OBJECTIVE: To analyse the frequency of mistakes in communication between the physician and the patient and their incidence in errors in self-administered drugs. METHODS: We undertook a descriptive, cross-sectional study based on interviews with a random sample of patients older than 65 years who were polymedicated (five or more drugs) and had multiple comorbidities. Data were analysed about the patients' reports of what the physician said, medication mistakes by the patients and their consequences. RESULTS: Responses were provided by 382 patients. A medication error in the last year was reported by 287 patients (75%), and 16 patients (4%) reported four or more errors. Most cases concerned the dosage, a similar appearance of the medication or a lack of understanding of the physician's instructions. Very severe consequences occurred in 19 cases (5%). Multiple comorbidities (P = 0.006) and a greater number of treatments (P = 0.002) were associated with making mistakes. Frequent changes in prescription (P = 0.02), not considering the prescriptions of other physicians (P = 0.01), inconsistency in the messages (P = 0.01), being treated by various different physicians at the same time (P = 0.03), a feeling of not being listened to (P < 0.001) or loss of trust in the physician (P < 0.001) were associated with making medication mistakes. CONCLUSIONS: Mistakes by polymedicated patients with multiple comorbidities represent a real risk that should be addressed by the professionals. A review should be made of the routine control questions that the physician asks the patient to identify what other drugs the patient may be taking that have been indicated by another physician.